Synexis® LLC nhasi yakazivisa dhata idzva rakanaka kubva muongororo yekuongorora mashandisirwo eDHP ™ Tekinoroji munzvimbo yekiriniki yakaburitswa mumagazini yazvino yeAmerican Journal of Infection Control (AJIC). Ongororo yakadzokororwa yakaongorora kushanda kweDHP ™ Technology, kuwedzera kune yakajairwa kucheneswa kwemaoko, mukuderedza hutachiona hunowanikwa muchipatara (HAIs) muchikamu chekuchengetedza zvakanyanya (ICU) chechipatara chevana oncology. Sechigadziriso tekinoroji yekuchenesa nharaunda, DHP ™ yakabatsira mukudzikiswa kweHAI mune ino kiriniki.
"Kuchenesa kwakajairwa uye disinfecting mapuroteni anogona kunge asina kukwana kuvarwere vasina immunocompromised vanonyanya kubatwa neHAIs," akadaro Dr. Mario Melgar, Medical Director weInfection and Control.
Chidzidzo ichi chakaitwa pakati paNdira 2019 naMbudzi 2020 pachipatara chevana ICU (PICU) kuUnidad Nacional de Oncología Pediátrica (UNOP), National Referral Center yeVana vane Cancer uye mudiwa wepasi rose weanotungamira cancer yevana muUS UNOP chipatara chevana vane 65-bed oncology chiri muGuatemala City, Guatemala. Kunyangwe vachitevedzera zvese zvinongedzo neCDC zvekudzivirira HAIs, DHP™ Tekinoroji yakawedzerwa kune yakajairwa kuchenesa kwezvakatipoteredza uye kuuraya utachiona muPICU kuona kushanda kwayo pamazinga eHAI.
“Chidzidzo ichi chinoratidza kukosha kweDHP™ Technology. Ndinofara kuona kuderera kukuru kwechiitiko cheC. diff muPICU yedu,” akadaro Dr. Alicia Chang, Dhipatimendi reZvirwere Zvinotapukira. "Tiri kuramba tichitevera nzira dzekudzivirira nekudzora dzakakurudzirwa neCDC, uye kuwedzera kweDHP ™ muhurongwa hwedu hwekuchenesa nharaunda kwakabatsira kukwirisa zvatakawana."
Pakati pa2019 na2020, kuwedzera kweDHP ™ mukucheneswa kwakajairika kwakakonzera kudzikiswa kwe44.3% muchiitiko cheHAI (mutsauko wechiitiko, IRD = -21.20, p=0.0277) muPICU, kusanganisira kudzikiswa kwe76.4% muClostridioides-yakabatana gastroenteritis. (IRD=-8.23, p=0.0482), zvichienzaniswa nenguva isati yaiswa DHP™. Pamusoro pezvo, nyaya imwe chete yechipatara-yakawana COVID-19-yakabatana isiri-pneumonia yekufema hutachiona yakaitika muPICU uko DHP ™ yakaiswa zvichienzaniswa nenzvimbo yekutonga isina DHP ™ iyo yakawana kuwedzera kwechipatara-yakawanikwa isiri-pneumonia yekufema zvirwere. Ird=2.52; p=0.028). Izvi zvinoenderana nezvidzidzo zvenguva pfupi yapfuura zvinoratidza kuti DHP™ inodzima SARS-CoV-2 mumhepo uye nepamusoro. 2,3; p=61.4). Chiitiko cheHAI hachina kunyanya kushanduka mune chimwe chikamu chechipatara umo DHP ™ yakanga isina kuiswa.
"Zvirwere zvinotorwa muchipatara zvakaita seCCIDID-19-yakabatana isiri-pneumonia yekufema hutachiona injodzi huru iyo kuchenesa nemaoko hakugone kubvisa zvizere," akadaro Eric Schlote, CEO weSynexis®. "Tinofara kuti DHP™ Tekinoroji iri kuenderera mberi ichiratidza kushanda zvakanaka mumakiriniki uye inogona kupa imwe chengetedzo kubva kuHAIs neSARS-COV-2."
Varwere vari muchidzidzo vakasiyana muzera kubva pamwedzi 1 kusvika kumakore makumi maviri nemaviri, neavhareji yemakore 22. Ruzhinji (7.7%) vaive varwere vane leukemia, asi vakasara vakaonekwa vaine dzimwe mhando dzegomarara, kusanganisira sarcoma, blastoma uye lymphoma. Varwere ava vari panjodzi huru yeHAI nekuda kwemamiriro avo ekudzivirira kudzivirira, kutarisana nemidziyo inoparadza uye maitiro, uye mamiriro ekurapa.61 DHP™ Technology yakaderedza HAI mazinga pasina kukonzera chero zviitiko zvakashata zvine chekuita nekusangana neDHP™.
Synexis® tekinoroji inoshandisa DHP™ kuchenesa mweya uye nzvimbo. DHP ™ mamorekuru anofamba munzvimbo yakavharirwa kuderedza mavhairasi, mabhakitiriya, mold, hwema uye tumbuyu twakawanda. Inogadzirwa kubva kune ambient humidity uye okisijeni iripo munharaunda, DHP ™ inogona kuendeswa zvinobudirira munzvimbo dzakagarwa pamazinga ari pasi peiyo occupational airborne safety standards yakagadzwa neOSHA, iyo inobvumira kuenderera mberi kuderedzwa kwehutachiona pasina kuvhiringidza mashandiro akajairika uye mafambiro ebasa.5 DHP™ is inokwanisa kukanganisa zvinosvibisa mumhepo nepanzvimbo munzvimbo dzakaoma-kusvika.
ZVOKUBVA MUNYAYA INO:
- The study was conducted between January 2019 and November 2020 at the pediatric ICU (PICU) at Unidad Nacional de Oncología Pediátrica (UNOP), the National Referral Center for Children with Cancer and a global partner of a leading pediatric cancer institution in the U.
- The retrospective analysis assessed the efficacy of DHP™ Technology, in addition to standard manual cleaning, in reducing hospital-acquired infections (HAIs) in the intensive care unit (ICU) of a pediatric oncology hospital.
- Additionally, only one case of hospital-acquired COVID-19-associated non-pneumonia respiratory infection occurred in the PICU where DHP™ was installed compared to a control area without DHP™ which experienced an increase in hospital-acquired non-pneumonia respiratory infections (IRD=2.
